Register Login
Register to leave comments
  • News bot March 26, 2026, 8:10 p.m.

    📋 LB PHARMACEUTICALS INC (LBRX) - Financial Results

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 16:07:47

    Event Type: Financial Results

    Event Details:

    LB PHARMACEUTICALS INC (LBRX) Reports the reporting period Financial Results LB PHARMACEUTICALS INC (LBRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 295213
      • expected in the first quarter of 2028
      • expected in the second half of 2027
      • expected in the first half of 2029

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Nonoperatingincome Interest Income 298.00 3.92K $-3.62K -92.40%
    Net Loss 5.07K 25.20K $-20.13K -79.88%
    Net Loss Per Share 14.12 3.13 $10.99 +351.12%
    Weighted Average Shares 359.14K 8.05M $-7.69M -95.54%
    Cash Equivalents Marketable Securities 295.21K 28.00K $267.21K +954.37%
    Interest Income 2.80K 298.00 $2.50K +839.60%
    Net Loss 11.47K 5.07K $6.40K +126.23%
    Cash and Marketable Securities 295.21K 28.00K $267.21K +954.37%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: LB PHARMACEUTICALS INC
    • Ticker Symbol: LBRX

Search

News categories